高级搜索

结肠癌干细胞与临床病理因素及survivin、Ki67表达的相关分析

柯金, 胡喜梅, 周水阳, 包维莺, 范燕琴, 陆翠, 戴永援, 朱锐锋, 王恒石, 刘媛

柯金, 胡喜梅, 周水阳, 包维莺, 范燕琴, 陆翠, 戴永援, 朱锐锋, 王恒石, 刘媛. 结肠癌干细胞与临床病理因素及survivin、Ki67表达的相关分析[J]. 肿瘤防治研究, 2012, 39(08): 950-953. DOI: 10.3971/j.issn.1000-8578.2012.08.017
引用本文: 柯金, 胡喜梅, 周水阳, 包维莺, 范燕琴, 陆翠, 戴永援, 朱锐锋, 王恒石, 刘媛. 结肠癌干细胞与临床病理因素及survivin、Ki67表达的相关分析[J]. 肿瘤防治研究, 2012, 39(08): 950-953. DOI: 10.3971/j.issn.1000-8578.2012.08.017
Ke Jin, Hu Ximei, Zhou Shuiyang, Bao Weiying, Fan Yanqin, Lu Cui, Dai Yongyuan, Zhu Ruifeng, Wang Hengshi, Liu Yuan. Relationship of Cancer Stem Cells with Clinical Pathologic Factors,survivin and Ki67 in Colorectal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(08): 950-953. DOI: 10.3971/j.issn.1000-8578.2012.08.017
Citation: Ke Jin, Hu Ximei, Zhou Shuiyang, Bao Weiying, Fan Yanqin, Lu Cui, Dai Yongyuan, Zhu Ruifeng, Wang Hengshi, Liu Yuan. Relationship of Cancer Stem Cells with Clinical Pathologic Factors,survivin and Ki67 in Colorectal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(08): 950-953. DOI: 10.3971/j.issn.1000-8578.2012.08.017

结肠癌干细胞与临床病理因素及survivin、Ki67表达的相关分析

详细信息
    作者简介:

    柯金(1977-),男,硕士,主治医师,主要从事肿瘤内科学研究

  • 中图分类号: R735.3

Relationship of Cancer Stem Cells with Clinical Pathologic Factors,survivin and Ki67 in Colorectal Carcinoma

  • 摘要: 目的 探讨肿瘤干细胞标志物CD133在结直肠癌组织中的表达,及其与临床病理因素、survivin和Ki67的关系。方法应用免疫组织化学方法检测60例手术切除的结直肠癌和30例癌旁组织及12例正常组织中CD133的表达、癌组织中survivin和Ki67的表达,对各指标之间的相关关系及其与性别、年龄、肿瘤的部位和大小、病理分级、侵袭深度、淋巴结转移、pTNM分期之间的关系进行分析。结果结直肠癌组织中CD133阳性表达率为50%(30/60),显著高于癌旁及正常组织(P<0.01);CD133的表达与淋巴结转移和pTNM分期密切相关(P<0.01),与病理分级存在相关性(P<0.05),与其他临床病理因素均无关;survivin的表达仅与肿瘤的病理分级相关(P<0.05),Ki67与各项临床病理参数均无相关性;CD133与survivin、Ki67的表达呈正相关(P<0.05、P<0.01);survivin与Ki67的表达呈正相关(P<0.01)。结论结直肠癌组织中存在CD133+肿瘤细胞,肿瘤干细胞在结直肠癌的发生、发展中起重要作用,检测肿瘤干细胞标志物CD133的表达可作为一种判断肿瘤的恶性程度和预后的重要指标。

     

    Abstract: Objective To explore the expression of cancer stem cell marker CD133 and to elucidate its relationship with the clinicopathological factors,survivin and Ki67 in colorectal cancer tissues. Methods Expressions of CD133,survivin and Ki67 were detected by immunohistochemical method in 60 cases of colorectal carcinoma,para-cancerous and normal colorectal tissues.The correlations between the various indicators as well as the relationship between these indicators and clinicopathological factors including gender,age,site of primary mass,tumor size,histological grade,lymph node metastasis,invasive depth and pTNM stage were analyzed. Results The positive rate of CD133 was 50% in the 60 cases of colorectal cancer,which was significantly higher than that in para-cancerous and normal colorectal tissues (P<0.01).Expression of CD133 was significantly associated with lymph node metastasis and pTNM stages (P<0.01),and correlated with histological grades statistically(P<0.05),but not related to other clinicopathological parameters.Expression of survivin was only related to histological grades of tumor(P<0.05).No correlation between Ki67 and any clinicopathological parameters.Expression of CD133 was positively correlated with the expressions of survivin and Ki67(P<0.05 and P<0.01),respectively.Expression of survivin was also positively correlated with the expression of Ki67(P<0.01). Conclusion CD133+ tumor cells exist in colorectal cancer tissues.Cancer stem cells play an important role in the carcinogenesis and progreis of colorectal cancer.The expression of cancer stem cell marker CD133 may be useful for evaluating the malignancy and prognosis of colorectal carcinoma.

     

  • [1] Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008[J].CA Cancer J Clin,2008,58(2):71-96.
    [2] Huang EH,Heidt DG,Li CW,et al.Cancer stem cells:a new paradigm for understanding tumorprogression and therapeutic resistance[J].Surgery,2007,141(4):415-9.
    [3] Spillane JB,Henderson MA.Cancer stem cells:a review[J].ANZ J Surg,2007,77(6):464-8.
    [4] Jordan CT.The leukemic stem cell[J].Best Pract Res Clin Haematol,2007,20(1):13-8.
    [5] Li F,Tiede B,Massagué J,et al.Beyond tumorigenesis:cancer stem cells inmetastasis[J].CellRes,2007,17(1):3-14.
    [6] Mizrak D,Brittan M,Alison MR.CD133:molecule of the moment[J].J Pathol,2008,214(1):3-9.
    [7] O′Brien CA,Pollett A,Gallinger S,et al.A human colon cancer cell capable of initiating tumourgrowth in immunodeficient mice[J].Nature,2007,445(7123):106-10.
    [8] Ieta K,Tanaka F,Haraguchi N,et al.Biological and genetic characteristics of tumor- initiatingcells in colon cancer[J].Ann Surg Oncol,2008,15(2):638-48.
    [9] Artells R,Moreno I,Díaz T,et al.Tumour CD133 mRNA expression and clinical outcome in surgicallyresected colorectal cancer patients[J].Eur J Cancer,2010,46(3):642-9.
    [10] Horst D,Scheel SK,Liebmann S,et al.The cancer stem cell marker CD133 hashigh prognostic impactbut unknown functional relevance for the metastasis of human colon cancer[J].J Pathol,2009,219(4):427-34.
    [11] MarkowitzSD,Bertagnolli MM.Molecular origins of cancer:molecular basis of colorectal cancer[J].N Engl J Med,2009,361(25):2449-60.
    [12] Lin LJ,Zheng CQ,Jin Y,et al.Expression of survivin protein in human colorectal carcinogenesis[J].World J Gastroenterol,2003,9(5):974-7.
    [13] Liu G,Yuan X,Zeng Z,et al.Analysis of gene expression and chemoresistance of CD133+cancer stemcells in glioblastoma[J].Mol Cancer,2006,5:67.
    [14] Tang BF,Ma LY,Zhai YJ,et al.Expression and clinical significance of cancer stem cell markerCD133 in gastric cancer tissues[J].Lin Chuang Zhong Liu Xue Za Zhi,2008,13(6):495-8.[唐毕锋,马立业,翟羽佳,等.肿瘤干细胞标志物CD133在胃癌中的表达及其临床意义[J].临床肿瘤学杂志,2008,13(6):495-8.]
    [15] Li YZ,Wang FH,Zhao P.Expressions of CD133 and Ki-67 in gastric carcinoma and theirclinicopathologic significances[J].Shi Jie Hua Ren Xiao Hua Za Zhi,2008,16(28):3167-71.[李亚卓,王凤华,赵坡.CD133、Ki-67在胃癌的表达及临床病理意义[J].世界华人消化杂志,2008,16(28):3167-71.]
计量
  • 文章访问数:  2403
  • HTML全文浏览量:  30
  • PDF下载量:  506
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-01-02
  • 修回日期:  2012-05-03
  • 刊出日期:  2012-08-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭